Noninvasive measurement of blood glucose is a holy grail of medicine, with the potential to revolutionize diabetes management. Integrity Applications, an Israeli firm, has developed a device that looks like a pulse oximeter that attaches to the ear lobe, but instead uses ultrasound, electromagnetic, and thermal data to measure the amount of glucose within the blood passing through the ear lobe. The firm already received the CE Mark for their technology in Europe and a clinical trial in preparation for FDA review is in the works.
Avner Gal, Co-Founder, President & CEO of Integrity Applications, joined us to discuss the company’s technology, how it can impact healthcare, and what the future holds for diabetes management and treatment.
Here’s a recording of the hangout:
Flashbacks: GlucoTrack Non-Invasive Ear Lobe Glucometer to Go to Clinical Trial in U.S…; GlucoTrack DF-F Noninvasive Glucose Meter Receives CE Mark…; Non-Invasive Measurement of Blood Glucose Levels Using GlucoTrack: Interview with CEO Avner Gal…;